In fact, simultaneous therapy using PD-1 inhibitors and targeting the adenosine pathway was more effective in improving survival, reducing tumor growth, and limiting metastasis than single therapy in some types of cancer (106–108). The gene discussed is PDCD1; the disease is neoplasm.